CLINICAL_TRIALS
trial_result
· 2012-02-14
Clinical Trial Update: Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer [Phase 2]
Summary
Phase 2 trial of pioglitazone in adults undergoing surgery for non-small cell lung cancer was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-02-14